Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story.
Boyd
I W
IW
D016907:Adverse Drug Reaction Reporting Systems; D001315:Australia; D056486:Chemical and Drug Induced Liver Injury; D004009:Dicloxacillin / Q000009:adverse effects*; D005436:Floxacillin / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D010406:Penicillins / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing
D010406:Penicillins; D005436:Floxacillin; D004009:Dicloxacillin